Darin BrownA correspondent from Estonia shared this recent news:
“Unique HIV is spreading in Estonia
Research has shown that recombined (?) [recombinant = hybrids of the known “strains”] form of HIV spreads in Estonia. People get infected locally and it is not brought in from abroad.
‘We have done more than 10 years of research and we do not have exporters [?importers?] of HIV, we do not get it from Russia or Western Europe’, says Irja Lutsar, professor of medical microbiology and virology. She added that people get infected with HIV locally and a recombined [recombinant] form of HIV is spreading here.
‘Our virus is unique but if you ask where it came from then I do not know answer to that.’”
Professor Lutsar might find some clues in de Harven’s article in Journal of the American Physicians and Surgeons as well as in The Case against HIV.
“Also, US, British and Finnish embassies here recently wrote a public letter to Estonian parliament about HIV”.
Part of that letter reads;
“The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest commitment by any nation to combat a single disease. Through PEPFAR, the U.S. government works with vulnerable, developing nations on a framework to combat HIV/AIDS. Since 2009, the U.S. government has committed nearly $65 billion to support PEPFAR and its global HIV/AIDS response. While gains have been real, progress against this disease, even in the United States, has been uneven.”
That inevitably brought to mind the quote attributed to the late Republican fiscal conservative, Senator Everett Dirksen:
“A billion here, a billion there, pretty soon, you’re talking real money”.
(As commonly with the most delightful quotes, this may be a mis-attribution)
At any rate, the United States has apparently disbursed $65 billion without anyone getting any benefit and some undoubtedly being harmed as a result of being fed toxic drugs while not only healthy but even HIV-negative.
I shouldn’t have said, of course, that no one benefited. The drug companies and their shareholders and executives have certainly benefited.
HIV/AIDS Skepticism 